

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of complement activation (GO:0045916) | 6.59034638 |
| 2 | keratan sulfate catabolic process (GO:0042340) | 6.27592009 |
| 3 | protein heterotrimerization (GO:0070208) | 6.16510435 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 5.69321330 |
| 5 | skin morphogenesis (GO:0043589) | 5.57584205 |
| 6 | positive regulation of respiratory burst (GO:0060267) | 5.49201378 |
| 7 | collagen fibril organization (GO:0030199) | 5.43561983 |
| 8 | negative regulation of protein activation cascade (GO:2000258) | 5.31637146 |
| 9 | cell migration involved in heart development (GO:0060973) | 5.16978150 |
| 10 | opsonization (GO:0008228) | 4.81039772 |
| 11 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.76500742 |
| 12 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.74816358 |
| 13 | negative regulation of humoral immune response (GO:0002921) | 4.59983494 |
| 14 | * collagen catabolic process (GO:0030574) | 4.58620432 |
| 15 | * collagen metabolic process (GO:0032963) | 4.54750804 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.38789464 |
| 17 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 4.24248893 |
| 18 | * multicellular organismal catabolic process (GO:0044243) | 4.20263646 |
| 19 | adhesion of symbiont to host cell (GO:0044650) | 4.14767537 |
| 20 | virion attachment to host cell (GO:0019062) | 4.14767537 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.06421963 |
| 22 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.04200406 |
| 23 | * multicellular organismal metabolic process (GO:0044236) | 4.00204575 |
| 24 | extracellular fibril organization (GO:0043206) | 3.88981642 |
| 25 | bone trabecula formation (GO:0060346) | 3.81268131 |
| 26 | * extracellular matrix disassembly (GO:0022617) | 3.78388428 |
| 27 | barbed-end actin filament capping (GO:0051016) | 3.73687415 |
| 28 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.71109640 |
| 29 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.67665868 |
| 30 | adhesion of symbiont to host (GO:0044406) | 3.64106479 |
| 31 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.62432736 |
| 32 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.61365729 |
| 33 | endodermal cell differentiation (GO:0035987) | 3.53213005 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.51623353 |
| 35 | fibril organization (GO:0097435) | 3.51008633 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.49456145 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.49456145 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.49456145 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.49456145 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.49456145 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 3.49456145 |
| 42 | chondrocyte proliferation (GO:0035988) | 3.46447786 |
| 43 | basement membrane organization (GO:0071711) | 3.45821742 |
| 44 | kidney mesenchyme development (GO:0072074) | 3.44310965 |
| 45 | metanephric mesenchyme development (GO:0072075) | 3.41861903 |
| 46 | type B pancreatic cell proliferation (GO:0044342) | 3.41733401 |
| 47 | positive regulation of macrophage activation (GO:0043032) | 3.41732884 |
| 48 | chondroitin sulfate catabolic process (GO:0030207) | 3.36525134 |
| 49 | positive regulation of osteoblast proliferation (GO:0033690) | 3.33507706 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.30638853 |
| 51 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.27410052 |
| 52 | extracellular matrix assembly (GO:0085029) | 3.23605731 |
| 53 | decidualization (GO:0046697) | 3.23181324 |
| 54 | hyaluronan catabolic process (GO:0030214) | 3.15333647 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 3.15125511 |
| 56 | regulation of macrophage cytokine production (GO:0010935) | 3.13126280 |
| 57 | apoptotic cell clearance (GO:0043277) | 3.12479082 |
| 58 | cell adhesion mediated by integrin (GO:0033627) | 3.08790174 |
| 59 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.06517754 |
| 60 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.06505433 |
| 61 | regulation of monocyte chemotaxis (GO:0090025) | 3.03792991 |
| 62 | extracellular negative regulation of signal transduction (GO:1900116) | 3.00480026 |
| 63 | extracellular regulation of signal transduction (GO:1900115) | 3.00480026 |
| 64 | detection of biotic stimulus (GO:0009595) | 2.98596086 |
| 65 | negative regulation of biomineral tissue development (GO:0070168) | 2.98376228 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96368753 |
| 67 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.93824007 |
| 68 | glomerular filtration (GO:0003094) | 2.92957478 |
| 69 | phagocytosis, recognition (GO:0006910) | 2.90861302 |
| 70 | glial cell migration (GO:0008347) | 2.89594202 |
| 71 | positive regulation of p38MAPK cascade (GO:1900745) | 2.88670600 |
| 72 | dermatan sulfate biosynthetic process (GO:0030208) | 2.87387016 |
| 73 | * extracellular matrix organization (GO:0030198) | 2.86888121 |
| 74 | blood vessel maturation (GO:0001955) | 2.86477877 |
| 75 | * extracellular structure organization (GO:0043062) | 2.85605105 |
| 76 | glycosphingolipid catabolic process (GO:0046479) | 2.84920088 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84640066 |
| 78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83934388 |
| 79 | chondrocyte development (GO:0002063) | 2.83875151 |
| 80 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.83336814 |
| 81 | substrate-dependent cell migration (GO:0006929) | 2.82838210 |
| 82 | middle ear morphogenesis (GO:0042474) | 2.82096378 |
| 83 | cellular response to vitamin D (GO:0071305) | 2.81200910 |
| 84 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.81109763 |
| 85 | glycosylceramide metabolic process (GO:0006677) | 2.81067573 |
| 86 | negative regulation of BMP signaling pathway (GO:0030514) | 2.80475203 |
| 87 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.79148866 |
| 88 | regulation of complement activation (GO:0030449) | 2.79091567 |
| 89 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.76905502 |
| 90 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.76154313 |
| 91 | endothelial cell proliferation (GO:0001935) | 2.71472177 |
| 92 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.71274107 |
| 93 | peptidyl-proline hydroxylation (GO:0019511) | 2.68411678 |
| 94 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66687188 |
| 95 | stress fiber assembly (GO:0043149) | 2.66611649 |
| 96 | biomineral tissue development (GO:0031214) | 2.66360918 |
| 97 | cellular response to cadmium ion (GO:0071276) | 2.66307327 |
| 98 | glycosaminoglycan catabolic process (GO:0006027) | 2.64394999 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.63306042 |
| 100 | cellular response to vitamin (GO:0071295) | 2.62168721 |
| 101 | protein localization to endosome (GO:0036010) | 2.62002613 |
| 102 | response to lipoprotein particle (GO:0055094) | 2.61561073 |
| 103 | positive regulation of extracellular matrix organization (GO:1903055) | 2.59854647 |
| 104 | dermatan sulfate metabolic process (GO:0030205) | 2.59447758 |
| 105 | renal filtration (GO:0097205) | 2.56691388 |
| 106 | smooth muscle tissue development (GO:0048745) | 2.55867637 |
| 107 | protein hydroxylation (GO:0018126) | 2.54860175 |
| 108 | negative regulation of cell junction assembly (GO:1901889) | 2.54309369 |
| 109 | negative regulation of adherens junction organization (GO:1903392) | 2.54309369 |
| 110 | negative regulation of focal adhesion assembly (GO:0051895) | 2.54309369 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54066070 |
| 112 | regulation of collagen metabolic process (GO:0010712) | 2.53817580 |
| 113 | angiogenesis involved in wound healing (GO:0060055) | 2.53776024 |
| 114 | glycolipid catabolic process (GO:0019377) | 2.53093438 |
| 115 | embryo implantation (GO:0007566) | 2.52497049 |
| 116 | protein localization to cell surface (GO:0034394) | 2.52273748 |
| 117 | regulation of apoptotic cell clearance (GO:2000425) | 2.52273548 |
| 118 | macrophage activation (GO:0042116) | 2.51073763 |
| 119 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.50838421 |
| 120 | protein trimerization (GO:0070206) | 2.50473185 |
| 121 | endocardial cushion development (GO:0003197) | 2.50280813 |
| 122 | ovulation from ovarian follicle (GO:0001542) | 2.50112292 |
| 123 | keratan sulfate metabolic process (GO:0042339) | 2.49690718 |
| 124 | regulation of granulocyte chemotaxis (GO:0071622) | 2.47823945 |
| 125 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.47270030 |
| 126 | axon extension involved in axon guidance (GO:0048846) | 2.47270030 |
| 127 | pinocytosis (GO:0006907) | 2.47170618 |
| 128 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.46788432 |
| 129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46532589 |
| 130 | tooth mineralization (GO:0034505) | 2.45955077 |
| 131 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.45305539 |
| 132 | cellular response to amino acid stimulus (GO:0071230) | 2.45253167 |
| 133 | aminoglycan catabolic process (GO:0006026) | 2.45081499 |
| 134 | regulation of early endosome to late endosome transport (GO:2000641) | 2.44951715 |
| 135 | positive regulation of receptor recycling (GO:0001921) | 2.44311833 |
| 136 | regulation of protein activation cascade (GO:2000257) | 2.44144550 |
| 137 | cortical actin cytoskeleton organization (GO:0030866) | 2.43765673 |
| 138 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.43404010 |
| 139 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.42922171 |
| 140 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.41994628 |
| 141 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.41531823 |
| 142 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.41314925 |
| 143 | sulfur compound catabolic process (GO:0044273) | 2.41159074 |
| 144 | regulation of leukocyte chemotaxis (GO:0002688) | 2.40608072 |
| 145 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.39078865 |
| 146 | glomerular basement membrane development (GO:0032836) | 2.38999529 |
| 147 | endothelial cell morphogenesis (GO:0001886) | 2.38652966 |
| 148 | neutrophil activation involved in immune response (GO:0002283) | 2.37958594 |
| 149 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37956437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.56748362 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.16260902 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 4.06883262 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90902523 |
| 5 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.89422426 |
| 6 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.87847287 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.73650698 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62780824 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.60465320 |
| 10 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.49886718 |
| 11 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.47018127 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.42811564 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.38062413 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35031135 |
| 15 | CJUN_26792858_Chip-Seq_BT549_Human | 2.32261391 |
| 16 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.27458912 |
| 17 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.27458912 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.20059575 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07398219 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05186953 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92628271 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.87389639 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85274604 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.80904830 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80883611 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78160670 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.76307131 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75253393 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.67385434 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64932013 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64372973 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.63618156 |
| 33 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60102950 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59824765 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59088840 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58202689 |
| 37 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57984266 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57700806 |
| 39 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56754863 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56354525 |
| 41 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50713724 |
| 42 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.49206760 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48238842 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46572090 |
| 45 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44224227 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42951039 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42661798 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38014647 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37692550 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36281431 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36281431 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34466816 |
| 53 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.27294293 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27190148 |
| 55 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25169713 |
| 56 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21276850 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20675399 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18259428 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14421629 |
| 60 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13497433 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12854232 |
| 62 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08209756 |
| 63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08173163 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06257069 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06249705 |
| 66 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04638079 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02584040 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02584040 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02087913 |
| 70 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01216006 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00479061 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99163436 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98954341 |
| 74 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98200722 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97962877 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97897191 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97735254 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95834697 |
| 79 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95615382 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95615382 |
| 81 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95559794 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95527880 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95489990 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94373552 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92928775 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92469145 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91181747 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91058698 |
| 89 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90802582 |
| 90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.90334673 |
| 91 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89983348 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89217036 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88541089 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88154482 |
| 95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88029837 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87879145 |
| 97 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87835505 |
| 98 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.87822318 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87290212 |
| 100 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84466394 |
| 101 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.84313895 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83566616 |
| 103 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.82142620 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81394031 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81349148 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80850914 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80480970 |
| 108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80130411 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80071804 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79345543 |
| 111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79224790 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79179672 |
| 113 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.78727081 |
| 114 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78723575 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.78270016 |
| 116 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.78138271 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77775643 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77710418 |
| 119 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.77158299 |
| 120 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.77071730 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.76410890 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75110332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 8.76053653 |
| 2 | MP0005503_abnormal_tendon_morphology | 5.72185826 |
| 3 | MP0005275_abnormal_skin_tensile | 5.13902280 |
| 4 | MP0006054_spinal_hemorrhage | 3.85267869 |
| 5 | MP0001958_emphysema | 3.81714194 |
| 6 | MP0003279_aneurysm | 3.35927890 |
| 7 | * MP0001542_abnormal_bone_strength | 2.80759465 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.77271862 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.38746568 |
| 10 | * MP0002998_abnormal_bone_remodeling | 2.30536574 |
| 11 | MP0004272_abnormal_basement_membrane | 2.23394205 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.22668598 |
| 13 | MP0002254_reproductive_system_inflammat | 2.12517497 |
| 14 | * MP0005508_abnormal_skeleton_morphology | 1.88846838 |
| 15 | MP0005164_abnormal_response_to | 1.88309962 |
| 16 | MP0002060_abnormal_skin_morphology | 1.74255852 |
| 17 | MP0002295_abnormal_pulmonary_circulatio | 1.72942347 |
| 18 | MP0004883_abnormal_blood_vessel | 1.71065379 |
| 19 | MP0005023_abnormal_wound_healing | 1.64890220 |
| 20 | MP0006082_CNS_inflammation | 1.64864252 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.64526473 |
| 22 | * MP0002896_abnormal_bone_mineralization | 1.62865986 |
| 23 | * MP0001533_abnormal_skeleton_physiology | 1.61227123 |
| 24 | MP0000343_altered_response_to | 1.59829252 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.57424386 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.55716993 |
| 27 | * MP0005390_skeleton_phenotype | 1.54879269 |
| 28 | MP0002933_joint_inflammation | 1.52858000 |
| 29 | MP0002108_abnormal_muscle_morphology | 1.52315518 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.39902238 |
| 31 | MP0005171_absent_coat_pigmentation | 1.37893990 |
| 32 | MP0001243_abnormal_dermal_layer | 1.36235214 |
| 33 | MP0004510_myositis | 1.35877259 |
| 34 | MP0003448_altered_tumor_morphology | 1.33815891 |
| 35 | * MP0003795_abnormal_bone_structure | 1.31889524 |
| 36 | MP0009250_abnormal_appendicular_skeleto | 1.30328008 |
| 37 | * MP0002115_abnormal_skeleton_extremities | 1.30119219 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.23096069 |
| 39 | MP0000767_abnormal_smooth_muscle | 1.21734698 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.18601419 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.18149134 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.16050412 |
| 43 | MP0000920_abnormal_myelination | 1.14164185 |
| 44 | MP0001299_abnormal_eye_distance/ | 1.12889928 |
| 45 | * MP0002419_abnormal_innate_immunity | 1.12303737 |
| 46 | * MP0000604_amyloidosis | 1.11597754 |
| 47 | MP0003283_abnormal_digestive_organ | 1.11574937 |
| 48 | * MP0000163_abnormal_cartilage_morphology | 1.11490899 |
| 49 | MP0002282_abnormal_trachea_morphology | 1.07102421 |
| 50 | * MP0002113_abnormal_skeleton_development | 1.02424369 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.01556779 |
| 52 | MP0009840_abnormal_foam_cell | 1.01187485 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.00977866 |
| 54 | MP0004134_abnormal_chest_morphology | 0.99184788 |
| 55 | MP0003950_abnormal_plasma_membrane | 0.97152263 |
| 56 | MP0003195_calcinosis | 0.97076215 |
| 57 | MP0003091_abnormal_cell_migration | 0.96450122 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 0.95271306 |
| 59 | MP0000751_myopathy | 0.95205333 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 0.91945451 |
| 61 | MP0005166_decreased_susceptibility_to | 0.90189043 |
| 62 | MP0004858_abnormal_nervous_system | 0.89045735 |
| 63 | MP0001849_ear_inflammation | 0.88897231 |
| 64 | MP0002133_abnormal_respiratory_system | 0.88235907 |
| 65 | MP0005388_respiratory_system_phenotype | 0.88235907 |
| 66 | MP0000858_altered_metastatic_potential | 0.85764666 |
| 67 | MP0003436_decreased_susceptibility_to | 0.85546182 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 0.85425816 |
| 69 | MP0009785_altered_susceptibility_to | 0.84855901 |
| 70 | MP0003303_peritoneal_inflammation | 0.83589567 |
| 71 | MP0008260_abnormal_autophagy | 0.79280071 |
| 72 | MP0000249_abnormal_blood_vessel | 0.78987447 |
| 73 | MP0003690_abnormal_glial_cell | 0.78065182 |
| 74 | MP0005408_hypopigmentation | 0.76158226 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.71069886 |
| 76 | MP0009278_abnormal_bone_marrow | 0.70355572 |
| 77 | MP0000733_abnormal_muscle_development | 0.70245189 |
| 78 | MP0001915_intracranial_hemorrhage | 0.69996383 |
| 79 | MP0000428_abnormal_craniofacial_morphol | 0.69482827 |
| 80 | MP0002168_other_aberrant_phenotype | 0.68754186 |
| 81 | MP0003329_amyloid_beta_deposits | 0.66688502 |
| 82 | MP0003941_abnormal_skin_development | 0.65387463 |
| 83 | MP0000685_abnormal_immune_system | 0.65028554 |
| 84 | MP0003075_altered_response_to | 0.64745647 |
| 85 | MP0000371_diluted_coat_color | 0.64592202 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.64236349 |
| 87 | MP0009764_decreased_sensitivity_to | 0.63618494 |
| 88 | MP0003634_abnormal_glial_cell | 0.63232546 |
| 89 | MP0005193_abnormal_anterior_eye | 0.61689196 |
| 90 | MP0001614_abnormal_blood_vessel | 0.61145583 |
| 91 | MP0002128_abnormal_blood_circulation | 0.61037382 |
| 92 | MP0001790_abnormal_immune_system | 0.60676237 |
| 93 | MP0005387_immune_system_phenotype | 0.60676237 |
| 94 | MP0003385_abnormal_body_wall | 0.60566749 |
| 95 | * MP0000432_abnormal_head_morphology | 0.59971151 |
| 96 | * MP0001175_abnormal_lung_morphology | 0.59526906 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.59104185 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.58587450 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.58354382 |
| 100 | MP0001851_eye_inflammation | 0.58151651 |
| 101 | MP0005197_abnormal_uvea_morphology | 0.57937260 |
| 102 | MP0000749_muscle_degeneration | 0.57570145 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57562759 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.57460241 |
| 105 | MP0010030_abnormal_orbit_morphology | 0.57380670 |
| 106 | MP0004084_abnormal_cardiac_muscle | 0.57223150 |
| 107 | MP0005165_increased_susceptibility_to | 0.56908593 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.56837373 |
| 109 | MP0003828_pulmonary_edema | 0.55641705 |
| 110 | MP0004484_altered_response_of | 0.54539345 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.54389650 |
| 112 | MP0003724_increased_susceptibility_to | 0.54375732 |
| 113 | MP0003045_fibrosis | 0.54142948 |
| 114 | MP0001177_atelectasis | 0.53950629 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.53148194 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.52904639 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.52391543 |
| 118 | MP0001835_abnormal_antigen_presentation | 0.51729240 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.51396174 |
| 120 | MP0010771_integument_phenotype | 0.51170420 |
| 121 | * MP0002109_abnormal_limb_morphology | 0.48445396 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.48280069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 7.95056434 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.82234775 |
| 3 | Broad metatarsal (HP:0001783) | 4.72156855 |
| 4 | Aortic dissection (HP:0002647) | 4.60987011 |
| 5 | Soft skin (HP:0000977) | 4.42965403 |
| 6 | Cervical subluxation (HP:0003308) | 4.36159501 |
| 7 | Atrophic scars (HP:0001075) | 4.00713945 |
| 8 | * Wormian bones (HP:0002645) | 3.76801857 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.75920789 |
| 10 | Abnormality of dentin (HP:0010299) | 3.67625693 |
| 11 | Ankle contracture (HP:0006466) | 3.61416788 |
| 12 | Bladder diverticulum (HP:0000015) | 3.59380040 |
| 13 | Shallow orbits (HP:0000586) | 3.54267319 |
| 14 | Aortic aneurysm (HP:0004942) | 3.48805900 |
| 15 | Peritonitis (HP:0002586) | 3.48260247 |
| 16 | Vascular tortuosity (HP:0004948) | 3.41267491 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.39511484 |
| 18 | Ulnar bowing (HP:0003031) | 3.39402405 |
| 19 | Purpura (HP:0000979) | 3.31911985 |
| 20 | Biconcave vertebral bodies (HP:0004586) | 3.28841211 |
| 21 | Follicular hyperkeratosis (HP:0007502) | 3.28420851 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.24486565 |
| 23 | Metaphyseal dysplasia (HP:0100255) | 3.23487662 |
| 24 | Arterial tortuosity (HP:0005116) | 3.22570817 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.22557693 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.22557693 |
| 27 | * Blue sclerae (HP:0000592) | 3.21379970 |
| 28 | Abnormal delivery (HP:0001787) | 3.09079786 |
| 29 | Fragile skin (HP:0001030) | 3.06533404 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.01459605 |
| 31 | Mild short stature (HP:0003502) | 3.00700810 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.00275541 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.98164576 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.98164576 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.98164576 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.91162619 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 2.91162619 |
| 38 | Nonimmune hydrops fetalis (HP:0001790) | 2.89614360 |
| 39 | Neonatal short-limb short stature (HP:0008921) | 2.89596456 |
| 40 | * Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.89339170 |
| 41 | * Osteolytic defects of the hand bones (HP:0009699) | 2.89339170 |
| 42 | Overgrowth (HP:0001548) | 2.84804648 |
| 43 | Redundant skin (HP:0001582) | 2.82216296 |
| 44 | Flared iliac wings (HP:0002869) | 2.81849178 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.81583241 |
| 46 | Femoral bowing (HP:0002980) | 2.80299538 |
| 47 | Hyperextensible skin (HP:0000974) | 2.79539710 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.78019009 |
| 49 | Coxa vara (HP:0002812) | 2.69138402 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.65828386 |
| 51 | Irregular vertebral endplates (HP:0003301) | 2.64942630 |
| 52 | Mitral valve prolapse (HP:0001634) | 2.64236379 |
| 53 | Genu recurvatum (HP:0002816) | 2.59449245 |
| 54 | Pulmonary artery stenosis (HP:0004415) | 2.57612244 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.56476008 |
| 56 | Ovoid vertebral bodies (HP:0003300) | 2.55266136 |
| 57 | Abnormality of the vertebral endplates (HP:0005106) | 2.54512065 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51634786 |
| 59 | Beaking of vertebral bodies (HP:0004568) | 2.50213644 |
| 60 | Abnormality of the acetabulum (HP:0003170) | 2.48573966 |
| 61 | Osteoarthritis (HP:0002758) | 2.41902419 |
| 62 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39241433 |
| 63 | Bowel diverticulosis (HP:0005222) | 2.37860423 |
| 64 | Platyspondyly (HP:0000926) | 2.37549090 |
| 65 | Wide anterior fontanel (HP:0000260) | 2.36387418 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.34862728 |
| 67 | Metaphyseal cupping (HP:0003021) | 2.30465441 |
| 68 | Spinal rigidity (HP:0003306) | 2.28168396 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.26356687 |
| 70 | Turricephaly (HP:0000262) | 2.25890960 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24398050 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24398050 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24398050 |
| 74 | Abnormal cartilage morphology (HP:0002763) | 2.24336472 |
| 75 | Bowed forearm bones (HP:0003956) | 2.23924779 |
| 76 | Bowing of the arm (HP:0006488) | 2.23924779 |
| 77 | Axonal loss (HP:0003447) | 2.23404218 |
| 78 | Joint laxity (HP:0001388) | 2.23091106 |
| 79 | Wrist flexion contracture (HP:0001239) | 2.22182410 |
| 80 | Slender build (HP:0001533) | 2.21612379 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.20504875 |
| 82 | Coronal craniosynostosis (HP:0004440) | 2.19770156 |
| 83 | Breech presentation (HP:0001623) | 2.18904286 |
| 84 | Abnormality of complement system (HP:0005339) | 2.17761072 |
| 85 | Aneurysm (HP:0002617) | 2.17309984 |
| 86 | Tibial bowing (HP:0002982) | 2.17098085 |
| 87 | Aortic valve stenosis (HP:0001650) | 2.16778416 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15912280 |
| 89 | Thoracolumbar scoliosis (HP:0002944) | 2.15615443 |
| 90 | Elbow flexion contracture (HP:0002987) | 2.13788527 |
| 91 | Radial bowing (HP:0002986) | 2.11279848 |
| 92 | Mitral regurgitation (HP:0001653) | 2.10598452 |
| 93 | * Delayed closure of the anterior fontanelle (HP:0001476) | 2.08717313 |
| 94 | Aortic regurgitation (HP:0001659) | 2.08411229 |
| 95 | Emphysema (HP:0002097) | 2.05914332 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 2.04548798 |
| 97 | Joint stiffness (HP:0001387) | 2.03817179 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03208171 |
| 99 | Nuclear cataract (HP:0100018) | 2.02741024 |
| 100 | Myocardial infarction (HP:0001658) | 2.01454961 |
| 101 | Abnormality of the lumbar spine (HP:0100712) | 2.01453917 |
| 102 | * Spondylolisthesis (HP:0003302) | 2.01398918 |
| 103 | Mitral stenosis (HP:0001718) | 2.00801534 |
| 104 | Cupped ribs (HP:0000887) | 1.99856902 |
| 105 | Disproportionate tall stature (HP:0001519) | 1.99510339 |
| 106 | Craniofacial hyperostosis (HP:0004493) | 1.98275916 |
| 107 | Hypoplasia of the odontoid process (HP:0003311) | 1.97390452 |
| 108 | Abnormality of skull ossification (HP:0002703) | 1.96157380 |
| 109 | Protuberant abdomen (HP:0001538) | 1.95133991 |
| 110 | Short hallux (HP:0010109) | 1.94712491 |
| 111 | * Delayed cranial suture closure (HP:0000270) | 1.93611124 |
| 112 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93213780 |
| 113 | Conjunctival telangiectasia (HP:0000524) | 1.92395614 |
| 114 | Inguinal hernia (HP:0000023) | 1.90679487 |
| 115 | J-shaped sella turcica (HP:0002680) | 1.90146611 |
| 116 | Enlarged epiphyses (HP:0010580) | 1.89840806 |
| 117 | Increased connective tissue (HP:0009025) | 1.89439383 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89182270 |
| 119 | Hypoventilation (HP:0002791) | 1.83060057 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83059519 |
| 121 | Gingival overgrowth (HP:0000212) | 1.82519652 |
| 122 | Neurofibrillary tangles (HP:0002185) | 1.82089909 |
| 123 | Osteopenia (HP:0000938) | 1.81963116 |
| 124 | Bell-shaped thorax (HP:0001591) | 1.81740609 |
| 125 | Natal tooth (HP:0000695) | 1.81669473 |
| 126 | Asymmetry of the thorax (HP:0001555) | 1.81515169 |
| 127 | Broad ribs (HP:0000885) | 1.81285187 |
| 128 | Cardiovascular calcification (HP:0011915) | 1.79717343 |
| 129 | Generalized amyotrophy (HP:0003700) | 1.78588044 |
| 130 | Spinal cord lesions (HP:0100561) | 1.76376177 |
| 131 | Syringomyelia (HP:0003396) | 1.76376177 |
| 132 | Complement deficiency (HP:0004431) | 1.75890958 |
| 133 | Skin nodule (HP:0200036) | 1.75651594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.43503505 |
| 2 | TGFBR2 | 3.40508119 |
| 3 | ERN1 | 2.99106894 |
| 4 | PBK | 2.73621204 |
| 5 | TRIB3 | 2.56065665 |
| 6 | PDGFRA | 2.55297621 |
| 7 | TRPM7 | 2.52311662 |
| 8 | BMX | 2.50737092 |
| 9 | PKN2 | 2.41791254 |
| 10 | EPHB1 | 2.37653727 |
| 11 | TTN | 2.37069150 |
| 12 | MET | 2.23702875 |
| 13 | CDC42BPA | 2.18534159 |
| 14 | LIMK1 | 2.03145444 |
| 15 | GRK7 | 1.87984369 |
| 16 | EPHA3 | 1.76786420 |
| 17 | KIT | 1.67695533 |
| 18 | PRKD2 | 1.59183641 |
| 19 | PAK4 | 1.58679829 |
| 20 | ABL2 | 1.57437826 |
| 21 | FGFR2 | 1.55481265 |
| 22 | FGR | 1.54335118 |
| 23 | NME2 | 1.53779994 |
| 24 | MST1R | 1.49145047 |
| 25 | ADRBK2 | 1.47218790 |
| 26 | BLK | 1.46594887 |
| 27 | TBK1 | 1.44304345 |
| 28 | TESK1 | 1.42783315 |
| 29 | EPHB2 | 1.42772148 |
| 30 | MYLK | 1.40438446 |
| 31 | LRRK2 | 1.39924807 |
| 32 | NTRK1 | 1.39698638 |
| 33 | RIPK1 | 1.36136730 |
| 34 | PIK3CG | 1.32614458 |
| 35 | MAP3K6 | 1.31819416 |
| 36 | PDK2 | 1.29925498 |
| 37 | DMPK | 1.28303956 |
| 38 | MAPKAPK5 | 1.25307397 |
| 39 | NEK9 | 1.21677520 |
| 40 | ERBB3 | 1.21600969 |
| 41 | PDGFRB | 1.20645270 |
| 42 | AKT3 | 1.19062586 |
| 43 | ROCK2 | 1.16158139 |
| 44 | GRK5 | 1.14077920 |
| 45 | ARAF | 1.09820200 |
| 46 | FGFR1 | 1.04460834 |
| 47 | ADRBK1 | 1.03410524 |
| 48 | PAK2 | 1.03264249 |
| 49 | STK39 | 1.03077754 |
| 50 | SIK1 | 0.98408328 |
| 51 | PIM2 | 0.97221716 |
| 52 | TYK2 | 0.96218997 |
| 53 | TGFBR1 | 0.93373921 |
| 54 | ILK | 0.93258766 |
| 55 | STK3 | 0.92682998 |
| 56 | STK38 | 0.92104984 |
| 57 | PTK2B | 0.91656091 |
| 58 | TAOK2 | 0.91363936 |
| 59 | FGFR4 | 0.90791432 |
| 60 | IRAK3 | 0.90709541 |
| 61 | ROCK1 | 0.88406618 |
| 62 | FER | 0.87852510 |
| 63 | MAP2K3 | 0.87808646 |
| 64 | MAP3K2 | 0.85976908 |
| 65 | PRKCH | 0.84371967 |
| 66 | MOS | 0.83548855 |
| 67 | PRPF4B | 0.83346085 |
| 68 | FLT3 | 0.83271338 |
| 69 | PLK2 | 0.83021192 |
| 70 | PTK6 | 0.81834761 |
| 71 | MAP3K3 | 0.79898894 |
| 72 | HCK | 0.78394224 |
| 73 | GRK1 | 0.77667207 |
| 74 | RPS6KA2 | 0.77533335 |
| 75 | MAPKAPK3 | 0.71896770 |
| 76 | PRKG2 | 0.71318903 |
| 77 | JAK3 | 0.70813515 |
| 78 | GSK3A | 0.70052849 |
| 79 | PRKD1 | 0.68936439 |
| 80 | DAPK3 | 0.68476080 |
| 81 | CSK | 0.68223400 |
| 82 | CSNK1A1L | 0.68025271 |
| 83 | NLK | 0.67914916 |
| 84 | MAPK12 | 0.67385509 |
| 85 | MAP3K14 | 0.65809888 |
| 86 | EGFR | 0.65436414 |
| 87 | FGFR3 | 0.65208382 |
| 88 | PDPK1 | 0.64958568 |
| 89 | CAMKK2 | 0.64266550 |
| 90 | ZAP70 | 0.61815779 |
| 91 | MARK3 | 0.61513247 |
| 92 | MAP3K13 | 0.60648718 |
| 93 | PTK2 | 0.60510455 |
| 94 | PAK1 | 0.60378854 |
| 95 | JAK1 | 0.59856114 |
| 96 | ERBB4 | 0.59752741 |
| 97 | INSR | 0.59093033 |
| 98 | BCR | 0.57956792 |
| 99 | LATS1 | 0.57022210 |
| 100 | CSNK1G3 | 0.56509195 |
| 101 | PKN1 | 0.55621873 |
| 102 | ABL1 | 0.54887053 |
| 103 | SRC | 0.53979401 |
| 104 | KSR2 | 0.51463046 |
| 105 | CAMK1D | 0.51437157 |
| 106 | CSNK1G1 | 0.51293714 |
| 107 | SCYL2 | 0.49568790 |
| 108 | RET | 0.49087199 |
| 109 | CSNK1G2 | 0.48746056 |
| 110 | FYN | 0.46625305 |
| 111 | PAK3 | 0.46359744 |
| 112 | OXSR1 | 0.45920630 |
| 113 | MAPKAPK2 | 0.45064249 |
| 114 | IGF1R | 0.44982184 |
| 115 | IKBKB | 0.43616047 |
| 116 | MAPK7 | 0.42904670 |
| 117 | IKBKE | 0.42901632 |
| 118 | RPS6KL1 | 0.41678978 |
| 119 | RPS6KC1 | 0.41678978 |
| 120 | MAP2K2 | 0.41655459 |
| 121 | PAK6 | 0.41613346 |
| 122 | GRK6 | 0.41001556 |
| 123 | MARK2 | 0.40831268 |
| 124 | LATS2 | 0.40546660 |
| 125 | CDK6 | 0.38582945 |
| 126 | MAP3K12 | 0.38173401 |
| 127 | DYRK1B | 0.38028776 |
| 128 | MAP3K1 | 0.37632054 |
| 129 | MAPK4 | 0.36962032 |
| 130 | CAMKK1 | 0.36562434 |
| 131 | STK4 | 0.34814891 |
| 132 | MTOR | 0.33869075 |
| 133 | MAP2K1 | 0.33868541 |
| 134 | CLK1 | 0.33673639 |
| 135 | ACVR1B | 0.33655618 |
| 136 | EEF2K | 0.33533721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.20630087 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 3.63434898 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.27670862 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.60895800 |
| 5 | Phagosome_Homo sapiens_hsa04145 | 2.56185356 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.55741101 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.41088036 |
| 8 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.35258179 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.35023863 |
| 10 | Amoebiasis_Homo sapiens_hsa05146 | 2.01387588 |
| 11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.93264636 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 1.88431983 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86831567 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.78188655 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66879153 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.63599414 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58923669 |
| 18 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57377723 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53747248 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53021650 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.51796551 |
| 22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.43028410 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.39168737 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26991586 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24279564 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24115285 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24010091 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20261906 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.19225561 |
| 30 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16651400 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13434154 |
| 32 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12297713 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08319057 |
| 34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08274639 |
| 35 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.07405129 |
| 36 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03937070 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.99670744 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99253216 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.95002011 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92345719 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91402821 |
| 42 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90477145 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88602150 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88040174 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87822369 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87172126 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86516006 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85362439 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85295600 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84904297 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 0.84806579 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83765195 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82532822 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.81661266 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.81406130 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81260332 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78859948 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77195473 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76986181 |
| 60 | * Apoptosis_Homo sapiens_hsa04210 | 0.74652269 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74303788 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73939390 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73613638 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72297724 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71916526 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68822292 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68688958 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68251600 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67360656 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67313439 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.66955676 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65932609 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.65759784 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65523613 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64364242 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64132201 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63604293 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62236901 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.61918841 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61386339 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61339834 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60190565 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60046394 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.59286928 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59086442 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58185399 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57586649 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56745010 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55377366 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.54852094 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52515644 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47866843 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47131415 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.46554793 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46500670 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46212622 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45327024 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45056628 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44401758 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43830368 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | 0.43762948 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42846989 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42779051 |
| 104 | Measles_Homo sapiens_hsa05162 | 0.42174682 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.41613907 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41250595 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40887743 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40880701 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40751332 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40527750 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39351817 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.38579440 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38051856 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.37330457 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37075983 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36881640 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.35171532 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.32754972 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32545339 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32482186 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.31386565 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30945800 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.24992300 |

